Radiotherapy (RT) is a common treatment for abdominal cancers like pancreatic tumors. Despite advancements in RT delivery, its effectiveness is hindered by the proximity of the radiosensitive intestine.
Category: Research
Develop strategies to ameliorate the course of Radiation-Induced Myocardial Fibrosis (RIMF)
Despite technological advancements in RT techniques, which enhance tumor targeting precision and minimize incidental cardiac doses, late cardiac toxicity remains a concern.
The role of STAT3 on pancreatic tumor radiosensitization
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal tumor, with a 5-year survival rate of approximately 11%. While RT is used to mitigate tumor recurrence in advanced pancreatic cancer, it frequently leads to severe gastrointestinal side effects.
Elucidate the role of ISR in the progression of pancreatic tumor and metastasis
Despite recent advances in prevention and treatment, pancreatic ductal adenocarcinoma (PDAC) remain highly aggressive and lethal due in part to their complex tumor microenvironment.
FLASH proton radiotherapy
Studies over the past decade suggest that ultra-high dose rates, exceeding 40 Gy/s, termed “FLASH” radiotherapy, improve the therapeutic index of radiation therapy (RT) by reducing normal tissue damage while maintaining tumor response compared to conventional RT.